What are the side effects of Axitinib?
Axitinibis used alone to treat advanced renal cell carcinoma (RCC, a cancer that begins in the cells of the kidney) when another drug does not work in patients. Citinib is used in combination with avelumab (Bavencio) or pembrolizumab (Keytruda) to treat advanced renal cell carcinoma (RCC). Aaxitinib belongs to the kinase inhibitor class of drugs. It works by blocking the activity of an abnormal protein that sends a reproduction signal to cancer cells. This helps slow down or prevent the spread of cancer cells.

Axitinib(Axitinib)The most common adverse reactions (≥20%) include the combination of axitinib and avelumab
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)